Skip to main content
IMAGION BIOSYSTEMS LIMITED logo

IMAGION BIOSYSTEMS LIMITED — Investor Relations & Filings

Ticker · IBX ISIN · AU000000IBX6 ASX Professional, scientific and technical activities
Open in API
Filings indexed 658 across all filing types
Latest filing 2023-03-06 Capital/Financing Update
Country AU Australia
Listing ASX IBX

About IMAGION BIOSYSTEMS LIMITED

https://imagionbiosystems.com/

Imagion Biosystems Limited is a medical technology company specializing in the development of advanced diagnostic imaging solutions. The company's proprietary MagSense technology utilizes superparamagnetic iron oxide nanoparticles to detect specific cancer cells non-invasively. By functionalizing these nanoparticles with targeting antibodies, the system can identify the presence and location of malignancies, such as HER2-positive breast cancer, using highly sensitive magnetic sensors. This approach aims to provide a safer, more accurate alternative to traditional biopsy and imaging methods by eliminating the need for ionizing radiation or radioactive tracers. The technology is designed to improve clinical decision-making through earlier detection and better staging of diseases, ultimately enhancing patient outcomes in oncology.

Recent filings

Filing Released Lang Actions
Imagion Funding Update 2 pages 144.7KB
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 7 March 2023 from Imagion Biosystems Limited regarding a shareholder entitlement offer to raise up to $2.4 million and a funding facility of up to $15 million secured with Mercer Street Global Opportunity Fund. It details the terms of the entitlement offer, the funding package, and the intended use of funds for clinical development and working capital. The document is focused on capital raising activities and financing updates rather than financial results, management changes, or regulatory filings. It does not contain financial statements or detailed financial analysis but rather describes fundraising efforts and capital structure changes. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is 6746 characters, which is sufficient for a detailed announcement but not a full financial report. Confidence in this classification is high given the clear focus on funding and capital raising.
2023-03-06 English
Imagion Secures Growth Funding 3 pages 159.7KB
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 7 March 2023 from Imagion Biosystems Limited regarding securing a funding facility of up to $15 million through convertible securities. It details the terms of the funding facility, including tranches, conversion rights, shareholder approval requirements, and use of funds. The content focuses on financing activities, capital raising, and related agreements. There is no indication that this is a full financial report, audit, or earnings release. The document is not a regulatory certification or a report publication announcement but a detailed update on capital raising and financing arrangements. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length (8789 characters) supports it being a substantive announcement rather than a brief notice.
2023-03-06 English
Non-renounceable Entitlement Offer 3 pages 135.5KB
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 7 March 2023 from Imagion Biosystems Limited regarding a non-renounceable entitlement offer to existing shareholders. It details the terms of the offer, including the issue price, record date, timetable, and use of funds. The content focuses on a capital raising event through issuing new shares to existing shareholders. There are no financial statements, quarterly or annual results, or management discussion of financial performance. The document is not a report but an update on a financing activity. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 5869 characters, which is sufficient for a detailed announcement but does not contain financial report data. Hence, the classification is CAP with high confidence.
2023-03-06 English
Entitlement Offer Offer Booklet 28 pages 312.6KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Non-renounceable Entitlement Offer' and details a pro-rata offer to existing shareholders to purchase new shares at a specified price to raise capital. It includes information about the offer terms, important dates, and a letter from the chairman explaining the purpose of the capital raise and related convertible securities agreement. The content focuses on fundraising activities and capital structure changes rather than financial results, management changes, or regulatory filings. The document is approximately 15,000 characters, indicating it is a full offer document rather than a brief announcement. Therefore, this document fits the category of a Capital/Financing Update (CAP).
2023-03-06 English
Cleansing Notice - Entitlement Offer 2 pages 126.7KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Cleansing Notice – Entitlement Offer Shares' and references a non-underwritten pro rata non-renounceable entitlement offer to raise approximately $2.4 million. It cites specific sections of the Corporations Act related to share issuance without disclosure and provides details about compliance and the potential effect on company control. The content focuses on the announcement of a capital raising event through an entitlement offer, which is a financing activity. The document is relatively short (3533 characters) and does not contain financial statements or detailed financial analysis, so it is not an Annual Report or Interim Report. It is not a report publication announcement since it contains substantive information about the entitlement offer itself. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2023-03-06 English
Proposed issue of securities - IBX 6 pages 31.9KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Proposed issue of securities' and contains detailed information about a new securities offering by Imagion Biosystems Limited. It includes specifics such as the type of issue (standard pro rata issue), number of securities to be issued, offer price, record dates, offer closing date, issue date, and details about fees and underwriting. The content is focused on the announcement of a capital raising event and the terms of the securities issuance. There are no financial statements or management discussion of financial results, so it is not an Annual Report, Interim Report, or Earnings Release. It is not a regulatory certification or legal proceeding. The document fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2023-03-06 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.